TechValidate Research on DrFirst

MedHx Case Study

University of Rochester Improves Medication Adherence with Insights from MedHx


This case study of the University of Rochester is based on a December 2021 survey of MedHx customers by TechValidate, a third-party research service.

“During their med history interview, a COPD patient reported that she takes her Spiriva Respimat® inhaler regularly, however, the MedHxSM report displayed an adherence rate of 61%. The pharmacist followed up on it with the patient, and she admitted it was hard for her to use because of her arthritis. She found the Spiriva Handihaler® in the hospital much easier to use, so on discharge her order was changed and a note sent to her PCP notifying them of the need to continue the Handihaler.” 

Siobhan deUrioste, PharmD, BCPS, Clinical Coordinator for the Surgical-Medicine Team, Pharmacy Department, University of Rochester Medical Center


The business challenges that led University of Rochester to evaluate and ultimately select MedHx:

  • Incomplete medication history data
  • Patients not taking medications as directed

The primary sources of readmissions:

  • Difficulty following home care and/or complications from home care

Use Case

Most effective methods or tools when helping their patients adhere to their treatment plans:

  • EHR functionality
  • Interviews with patients and family members
  • Meds to beds program


  • Since integrating with MedHx, University of Rochester is saving over two hours a day previously spent gathering and confirming a patient’s medication list.

University of Rochester achieved the following results with MedHx:

  • Feels their patient records are 85% complete

About This Data

This data was sourced directly from verified users of DrFirst by TechValidate.

TechValidate verifies the identity and organizational affiliation of all participants that contribute to published research data. When research participants so desire, we also guarantee their anonymity so that they may share information honestly and freely.

More Research on DrFirst